• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmedicine

Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world

Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
September 2, 2021, 6:38 AM ET

Ivermectin is an antiparasitic pill mainly used to deworm horses and cows. It is also, according to podcast star Joe Rogan, a great way to treat COVID-19.

Even before the endorsement from Rogan, who recently came down with COVID-19 and treated it with a cocktail of drugs unproven to be effective against the illness, ivermectin had been growing in popularity. In places like Brazil, Bolivia, Peru, and South Africa—along with the U.S.—people were using it to self-medicate against COVID-19.

Google searches for ivermectin are at an all-time high. Searches for ivermectin jumped alongside other at-home remedies like “hydroxychloroquine” at the start of the pandemic in March 2020, but while the Trump-backed hydroxychloroquine fell out of favor, ivermectin maintained its popularity. Prescriptions for ivermectin jumped to more than 88,000 in the week ended Aug. 13, and some pharmacists have even reported shortages of the drug.

But as with many unproven medicines, it can have fatal consequences.

Calls to poison control centers about ivermectin exposures have risen fivefold over the baseline in July, according to CDC researchers who used data from the American Association of Poison Control Centers.

Mississippi’s health department even issued an alert in August saying 70% of recent calls to the state poison control center had come from people who over-ingested ivermectin from livestock supply stores.

Such dangerous effects from self-prescription have prompted Merck, the manufacturer of the drug, to come out and say there was no scientific basis for ivermectin to be used as treatment against COVID-19 and the Food and Drug Administration to caution against ingestion of the medicine, warning that “using the drug ivermectin to treat COVID-19 can be dangerous and even lethal.”

Beyond ivermectin’s potential dangers, the drug also appears to offer little benefit in the fight against COVID. Researchers looking into the efficacy of ivermectin as a COVID-19 treatment had to shut down a large 1,300 patient trial because the drug had been no better than a placebo at preventing hospitalizations. Dr. Edward Mills, a professor at McMaster University who led the study, noted the team would have discontinued it earlier were it not for the level of public interest in ivermectin.

Researchers and physicians are particularly worried by people who are seeking out ivermectin to prevent COVID-19 in lieu of getting a vaccine.

But this has not stopped Rogan, the popular podcast host who has already been in hot water for suggesting young, fit people don’t need to get the COVID-19 vaccine.

After announcing a few canceled tour dates owing to his illness, Rogan gave a shout-out to the medicine, saying “a wonderful, heartfelt thank you to modern medicine for pulling me out of this so quickly and so easily.”

https://www.instagram.com/p/CTSsA8wAR2-/

Instagram captioned his post with a short warning: “Some unapproved COVID-19 treatments may cause serious harm.”

Facebook, owner of Instagram, did not respond to requests for comment.

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.
About the Author
Sophie Mellor
By Sophie Mellor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Lists Calendar
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Lists Calendar
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

suicide
Healthsuicide
Young adult suicide rate down 11% over 2.5 years of new 988 mental health crisis hotline
By Devi Shastri and The Associated PressApril 24, 2026
4 hours ago
kiani
CommentaryHealth
We could cut 180,000 preventable hospital deaths a year. Here’s exactly why we haven’t
By Joe KianiApril 24, 2026
4 hours ago
The man who helped put meat at the top of RFK Jr.’s new food pyramid is Steak ’n Shake’s new ‘Chief MAHA Officer’
HealthFood and drink
The man who helped put meat at the top of RFK Jr.’s new food pyramid is Steak ’n Shake’s new ‘Chief MAHA Officer’
By Catherina GioinoApril 23, 2026
18 hours ago
ken
Commentary250 Years of Innovation
The longevity revolution is here. Our systems still think we die at 65
By Ken DychtwaldApril 23, 2026
19 hours ago
cdc
PoliticsCDC
CDC blocks release of study on COVID vaccine effectiveness
By Mike Stobbe and The Associated PressApril 23, 2026
22 hours ago
Sad nurse sitting on stairs reading bad news on mobile phone
Economygig economy
The tech industry is applying an Uber-style ‘gigification’ model to nursing. It means no workers’ comp, AI managers, and ‘surveillance wages’
By Tristan BoveApril 23, 2026
22 hours ago

Most Popular

Despite nearing their 60s, nearly four in 10 Americans heading towards the end of their careers don’t even have a retirement account
Success
Despite nearing their 60s, nearly four in 10 Americans heading towards the end of their careers don’t even have a retirement account
By Emma BurleighApril 23, 2026
1 day ago
When interest on national debt overtook military spending, it triggered a limit where the U.S. may ‘cease to be a great power,’ warns Hoover historian
Economy
When interest on national debt overtook military spending, it triggered a limit where the U.S. may ‘cease to be a great power,’ warns Hoover historian
By Eleanor PringleApril 23, 2026
1 day ago
‘Don’t leave’: Jensen Huang challenges billionaire class as he insists ‘highest taxes in the world’ are OK with him
Big Tech
‘Don’t leave’: Jensen Huang challenges billionaire class as he insists ‘highest taxes in the world’ are OK with him
By Jacqueline MunisApril 23, 2026
18 hours ago
Cursor’s 25-year-old CEO is a former Google intern who just inked a $60 billion deal with SpaceX
AI
Cursor’s 25-year-old CEO is a former Google intern who just inked a $60 billion deal with SpaceX
By Marco Quiroz-GutierrezApril 22, 2026
2 days ago
The Iran war is pushing Southeast Asia to debate the once unthinkable: Whether ships will need to pay to transit the Strait of Malacca
Economy
The Iran war is pushing Southeast Asia to debate the once unthinkable: Whether ships will need to pay to transit the Strait of Malacca
By Angelica AngApril 23, 2026
1 day ago
The Gen Z Pout and the Gen Z Stare are both a warning to Fortune 500 CEOs
Future of Work
The Gen Z Pout and the Gen Z Stare are both a warning to Fortune 500 CEOs
By Nick LichtenbergApril 23, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.